San Diego-centered Viking Therapeutics marked by itself as a significant competitor during the weight loss drug sector in February right after revealing promising facts from a mid-phase trial of experimental drug VK2735, which proposed it rivaled—and outperformed—Novo and Lilly drugs when presented like a weekly injection and in March the compa… Read More